Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving medical devices and drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Beasley Allen appointed to leadership role in Johnson & Johnson talc MDL

December 6, 2016 - Leigh O’Dell, Beasley Allen Principal, will serve as Co-Lead Counsel for multidistrict litigation (MDL) involving the Johnson & Johnson talc litigation consolidated in Trenton, N.J. Read More


Johnson & Johnson, DePuy Orthopaedics hit with $1 billion verdict in third hip implant bellwether trial

December 1, 2016 - Texas jurors deliberated for less than a day before returning a verdict finding Johnson & Johnson’s DePuy Orthopaedics Inc. unit liable for injuries related to its Pinnacle metal-on-metal... Read More




Jury finds Johnson & Johnson, Imerys liable for $70 million in third ovarian cancer talc trial

October 27, 2016 - A third St. Louis jury has found Johnson & Johnson liable for ovarian cancer linked to talcum powder in its Johnson’s Baby Powder and Shower to Shower products. Talc supplier Imerys also... Read More


Diabetes drug Invokana linked to ketoacidosis

September 30, 2016 - Invokana, which contains the drug ingredient canagliflozin, was approved by the Food and Drug Administration (FDA) in March 2012. Read More


New Jersey Court ruling in talc hearing ignores internal documents

September 6, 2016 - Ruling to strike expert witnesses in New Jersey litigation ignores J&J admission that talc products carry ovarian cancer risk. Read More


Jere Beasley challenges J&J to release all talc documents, trial transcripts

August 25, 2016 - Announcing its appeal of two multimillion-dollar verdicts linking talc to ovarian cancer, Johnson & Johnson claims plaintiff lawyers created confusion about the link, while denying its own... Read More


Ted Meadows discusses most recent talcum powder verdict on the Beasley Allen Report

August 3, 2016 - Ted Meadows, Principal at the Beasley Allen Law Firm, visits the Beasley Allen Report to discuss the recent talcum powder verdict and how the verdict may change the way products are labeled. Read More


Possible serious side effects of PPI heartburn drugs include increased risk of kidney disease

June 29, 2016 - The research looked at the treatment of nearly 200,000 patients for more than five years and found approximately 20 percent higher risk of kidney disease in PPI users. Read More


back to top